 
                        | Product NDC: | 52959-014 | 
| Proprietary Name: | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | 
| Non Proprietary Name: | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | 
| Active Ingredient(s): | 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g & nbsp; Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | OINTMENT | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 52959-014 | 
| Labeler Name: | H.J. Harkins Company, Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | part333B | 
| Marketing Category: | OTC MONOGRAPH FINAL | 
| Start Marketing Date: | 20100106 | 
| Package NDC: | 52959-014-05 | 
| Package Description: | 14.17 g in 1 TUBE (52959-014-05) | 
| NDC Code | 52959-014-05 | 
| Proprietary Name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | 
| Package Description | 14.17 g in 1 TUBE (52959-014-05) | 
| Product NDC | 52959-014 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | 
| Dosage Form Name | OINTMENT | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20100106 | 
| Marketing Category Name | OTC MONOGRAPH FINAL | 
| Labeler Name | H.J. Harkins Company, Inc. | 
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | 
| Strength Number | 400; 5; 5000 | 
| Strength Unit | [USP'U]/g; mg/g; [USP'U]/g | 
| Pharmaceutical Classes |